Ximelagatran, a new oral anticoagulant--how will it affect laboratory practice? A clinical perspective.
Machin
Samuel J
SJ
Department of Haematology, UCL, UK.
D000925:Anticoagulants / Q000008:administration & dosage / Q000097:blood* / Q000191:economics; D001384:Azetidines / Q000008:administration & dosage / Q000097:blood* / Q000191:economics; D001596:Benzylamines; D001780:Blood Coagulation Tests / Q000191:economics / Q000379:methods; D002318:Cardiovascular Diseases / Q000097:blood* / Q000188:drug therapy / Q000191:economics / Q000209:etiology / Q000517:prevention & control; D016903:Drug Monitoring / Q000191:economics* / Q000379:methods; D006405:Hematology / Q000191:economics*; D006801:Humans; D007753:Laboratories / Q000191:economics*
D000925:Anticoagulants; D001384:Azetidines; D001596:Benzylamines; C426686:ximelagatran